1 of 1
Story summary
- Weight loss injections, including Mounjaro and Wegovy, have 2.5 million UK users as of July 2025.
- Health Secretary Wes Streeting aims to expand the National Health Service (NHS) access beyond severe obesity.
- Many patients turn to private purchases as NHS access remains rationed.
- Scams around weight loss products have surged, with Santander reporting losses.
- Obesity specialists advocate these injections as first-line treatments, citing effectiveness.
